Trial Profile
Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Feb 2022
Price :
$35
*
At a glance
- Drugs Malaria vaccine live unattenuated-Sanaria (Primary) ; Chloroquine
- Indications Malaria
- Focus Adverse reactions
- Sponsors Sanaria
- 12 Mar 2015 New source identified and integrated (European Clinical Trials Database; EudraCT2012-000322-21)
- 14 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jan 2014 According to ClinicalTrials.gov record trial status changed from recruiting to active, no longer recruiting.